Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	579.77B
Revenue (ttm)	810.68B
Net Income (ttm)	26.03B
Shares Out	12.18M
EPS (ttm)	2,134.05
PE Ratio	22.30
Forward PE	n/a
Dividend	525.00 (1.10%)
Ex-Dividend Date	Jun 27, 2025

Volume	77,206
Average Volume	54,844
Open	46,450
Previous Close	47,600
Day's Range	46,350 - 49,400
52-Week Range	20,500 - 53,200
Beta	1.06
RSI	56.17
Earnings Date	May 8, 2025

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 121
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.